Article
An analysis of the impact of annual cancer genetic testing guideline updates on a past patient population.
Journal of genetic counseling - 1 Oct 2024
Johnson Jordan, Hogan Elizabeth, Merrill Michelle, Noss Ryan
Abstract excerpt
Germline genetic testing for cancer predisposition genes has become an essential component of cancer treatment and risk reduction. The National Comprehensive Cancer Network (NCCN) releases annual genetic testing guidelines that identify characteristics of patients that could be affected by a hereditary cancer syndrome. These guidelines have broadened over time and the implications for past patients of cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
